News Headlines Article

Drug moves toward FDA approval for HIV prevention
Los Angeles Times

A pill that has long been used to treat HIV has moved a step closer to becoming the first drug approved in the U.S. to prevent healthy people from becoming infected with the virus that causes AIDS.

The Food and Drug Administration said Tuesday that Gilead Sciences’ Truvada appears to be safe and effective for HIV prevention. It concluded that taking the pill daily could spare users “infection with a serious and life-threatening illness that requires lifelong treatment.”